Pfizer vaccine is a combined vaccine against common and serious diseases in children, including whooping cough, diphtheria, tetanus, poliomyelitis, pneumococcal diseases and influenza. Its introduction provides a more convenient choice for children to be vaccinated, and also provides new hope for China to fight the epidemic.
2. The global application of Pfizer -8 vaccine.
Pfizer eight-vaccine is the world's first eight-vaccine, which has been listed in more than 40 countries and regions around the world and is widely used. Worldwide, the eight-vaccine has become one of the main means to prevent these children's common and serious diseases. This shows that the reputation and safety of Pfizer's eight-vaccine in the vaccine market have been recognized globally.
3. The time when Pfizer's vaccine entered China.
202165438+1On October 23rd, China State Administration of Pharmaceutical Products officially approved the marketing of Pfizer -8 vaccine. This is the first time that China has approved vaccine development enterprises across regions. The listing of Pfizer -8 vaccine is expected to fill the gap in children's vaccination in China and help more families fight diseases.
4. The significance and prospect of Pfizer -8 vaccine.
The marketing of Pfizer -8 vaccine will provide a new and more comprehensive prevention option for vaccination. It will greatly improve the efficiency and quality of vaccination, reduce the frequency and cost of vaccination, and bring more scientific, safer and more comprehensive vaccine protection to children. With the rapid development of China's vaccine market, the popularization and application of octuple vaccine will surely achieve a broader market prospect.